SCHEMBL5688744

SCHEMBL5688744

O=C(Oc1ccc(CCOc2ccccn2)cc1)N1CCC(On2ccnc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.38
FAAH O00519 2/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
GAA P10253 1/20 0.36
LIPE Q05469 1/20 0.36
NPY2R P49146 1/20 0.36
SLC6A7 Q99884 1/20 0.36
GPR119 Q8TDV5 1/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP3A4 P08684 3/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP2C9 P11712 2/20 0.35
MAPK1 P28482 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ACACB O00763 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5689023 0.88 GRIN2B (0.41) GRIN2BNPC1RAB9AGAALIPE
SCHEMBL5691062 0.87 FAAH (0.40) FAAHNPC1RAB9ANPY2RSLC6A7
SCHEMBL5689039 0.86 FAAH (0.39) FAAHNPC1RAB9AGAAMGLL
SCHEMBL5687295 0.85 NPC1 (0.40) GRIN2BNPC1RAB9AGAALIPE
SCHEMBL5689569 0.85 FAAH (0.39) GRIN2BFAAHNPC1RAB9AGAA
SCHEMBL5690784 0.84 FAAH (0.39) FAAHNPC1RAB9AGAALIPE
SCHEMBL5690386 0.81 LIPE (0.46) GRIN2BNPC1RAB9ALIPEGPR119
SCHEMBL5689283 0.81 FAAH (0.37) GRIN2BFAAHNPC1RAB9AGAA
SCHEMBL5689947 0.80 ALDH1A1 (0.37) GRIN2BFAAHNPC1RAB9AGAA
SCHEMBL5688487 0.80 EPHX2 (0.48) GRIN2BNPC1RAB9AGAAGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160851-A1 Substituted piperidine carbamates LIPE, PNLIP, LIPC GRIN2B 2588/4885FAAH 160/4885NPC1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.